FDA.reportPublic FDA data

Application 206432

Type
ANDA
Sponsor
CADILA PHARMS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NATEGLINIDENATEGLINIDETABLET;ORAL60MGNoNo
002NATEGLINIDENATEGLINIDETABLET;ORAL120MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
71209-030NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-030NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-030NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-030NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-030NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-031NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-031NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-031NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-031NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
71209-031NateglinideNateglinideCadila Pharmaceuticals LimitedANDACurrent
72241-002NateglinideNateglinideModavar Pharmaceuticals LLCANDACurrent
72241-003NateglinideNateglinideModavar Pharmaceuticals LLCANDACurrent
75834-205NATEGLINIDENATEGLINIDENivagen Pharmaceuticals, Inc.ANDACurrent
75834-205NATEGLINIDENATEGLINIDENivagen Pharmaceuticals, Inc.ANDACurrent
75834-206NATEGLINIDENATEGLINIDENivagen Pharmaceuticals, Inc.ANDACurrent
75834-206NATEGLINIDENATEGLINIDENivagen Pharmaceuticals, Inc.ANDACurrent